Leclercia adecarboxylata has been rarely isolated from environmental and clinical specimens. On review of the world literature, we found two reports of L. adecarboxylata infection: one report described a patient with hepatic cirrhosis, and the other described a child dependent on total parenteral nutrition. L. adecarboxylata was isolated from five infected patients who were evaluated at our institution. Three patients had lower-extremity wound infections in which L. adecarboxylata was part of a mixed microbial growth. One patient had pneumonia due to multiple bacteria, including L. adecarboxylata, which were isolated from sputum. L. adecarboxylata was isolated from the blood of one patient with neutropenia and from the blood of the two patients reported in the literature. All patients except one had fever and leukocytosis. L. adecarboxylata isolates were susceptible to all the antimicrobials tested. L. adecarboxylata is most frequently isolated as part of a mixed microbial growth. Its role in these infections is not clear. However, the organism caused bacteremia in three patients.
The introduction of new techniques such as DNA-DNA hypapers published from 1962 through 1995. Secondary references in the retrieved articles were also reviewed. bridization and species-or genus-specific bacteriophages has led to the recognition of new genera, species, and biogroups of Enterobacteriacae [1 -4] . Leclercia adecarboxylata, first de-
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scribed by Leclerc in 1962 [5] , is a motile, gram-negative bacillus, formerly designated enteric group 41 and Escherichia All L. adecarboxylata isolates were identified by colonial adecarboxylata [6, 7] . On reviewing the world literature, we and microscopic morphology and by an array of biochemical found only two case reports of L. adecarboxylata infection [8, tests. An initial group of tests was performed by use of the 9]. We also describe five patients who were evaluated at our CARP (Computer Assisted Replica Plate) system, a semiautoinstitution and who had infections from which L. adecarboxymated microbial identification system developed in-house at the lata was isolated.
Mayo Clinic [10] . These tests and their characteristic reactions included citrate (negative), lysine decarboxylase (negative), ornithine decarboxylase (negative), DNase (negative), hydrogen Methods sulfide (negative), esculin hydrolysis (positive), arginine dihy-A case was defined as the isolation of L. adecarboxylata drolase (negative), D-glucose (positive), lactose fermentation from culture of a specimen from any body site in a patient (positive), D-mannitol fermentation (positive), and L-arabinose evaluated at the Mayo Clinic (Rochester, MN) during the pefermentation (positive). riod 1984 -1995. A second group of biochemical tests was also performed Cases were identified through a review of a computerized using a manual tube set. These tests and their characteristic database, which contains the results for all cultures performed results included indole production (positive), methyl red (posiby the clinical microbiology laboratory at the Mayo Clinic for tive), Voges-Proskauer (negative), malonate utilization (posithe period 1984 -1995. The medical records of each patient tive), adonitol fermentation (positive), inositol fermentation from whom L. adecarboxylata was isolated during this period (negative), D-sorbitol fermentation (negative), and nitrate rewere reviewed for age, sex, clinical presentation, presence of duction (positive). underlying illnesses, co-morbidity conditions, treatment, and Antimicrobial susceptibility testing was performed using an outcome. agar dilution method previously described [10] . The results Relevant articles were identified by review of the medical for susceptibility testing were interpreted according to 1995 literature on L. adecarboxylata through a MEDLINE search of guidelines published by the National Committee for Clinical Laboratory Standards (NCCLS) [11] .
She was afebrile but had an elevated WBC count of 14.6 1 col. The patient was treated with iv aztreonam in the hospital, followed by oral ciprofloxacin as an outpatient. 10 9 /L. Her medical history was remarkable for depression, a personality disorder, and retinitis pigmentosa. Cultures of the Case one from the literature. A 45-year-old male with a wound yielded L. adecarboxylata and Staphylococcus aureus.
history of alcoholic cirrhosis presented with severe abdominal The L. adecarboxylata isolate was susceptible to all the antimipain, hypotension, tachycardia, and diaphoresis 6 hours after crobial agents tested including gentamicin, amikacin, cefazolin, undergoing paracentesis for the removal of ascitic fluid [8] . He ciprofloxacin, trimethoprim-sulfamethoxazole, imipenem, and was found to have hemoperitoneum and underwent a laparotampicillin. The patient was treated with oral ciprofloxacin, and omy. Four days later, he developed fever (temperature to her wound and cellulitis resolved.
38.6ЊC). Three blood cultures were performed, from which Patient 2. A previously healthy 35-year-old male sustained L. adecarboxylata was later identified. Despite the provision a severe crush injury to his right foot, causing compound of antibiotic therapy, the patient developed oliguric renal failure wounds and fracture dislocation of all metatarsal bones. On and died. initial presentation, he had a temperature of 39.0ЊC. fever, which started Ç1 hour after receiving total parenteral pneumoniae, Stenotrophomonas maltophilia, and Corynebactenutrition through a central line catheter [9] . On initial examinarium, Acremonium, Penicillium, Mucor, and Geotrichum spetion, he was febrile (temperature, 103ЊF) and his blood pressure cies. Antimicrobial susceptibility testing of the L. adecarboxywas 103/71 mm Hg. His WBC count was 12,500/mm 3 with a lata isolate was not performed. The patient underwent differential of 67 segmented neutrophils, 15 band forms, 12 amputation of his foot and completed a 24-day course of intralymphocytes, and 6 monocytes. Two blood cultures were pervenous therapy, which included one or more of the following formed; one specimen was from the central line and one was antimicrobials at any one time: cefazolin, ampicillin-sulbactam, obtained peripherally by venipuncture. ticarcillin-clavulanic acid, and ceftazidime.
After 24 hours, the culture of blood from the central line Patient 3. A 23-year-old otherwise healthy male was puncyielded L. adecarboxylata that was susceptible to amikacin, tured by a nail in the plantar aspect of his left third toe while ampicillin, cefazolin, cefoperazone, ceftazidime, gentamicin, working in a barnyard. He experienced fever (temperature to mezlocillin, piperacillin, tobramycin, and trimethoprim-sulfa-38.3ЊC) and chills. His WBC count was 12.6 1 10 9 /L. Culture methoxazole. Initial treatment with iv vancomycin, ceftaziof his wound yielded Acinetobacter calcoaceticus, Enterobacdime, and gentamicin was modified to ceftazidime and gentater agglomerans, as well as L. adecarboxylata. Antimicrobial micin, and the patient completed a 14-day course of this susceptibility testing for the L. adecarboxylata isolate was not regimen. Fever and leukocytosis resolved promptly following performed. The patient was treated with oral ciprofloxacin, initiation of antimicrobial therapy. The central catheter was not which resulted in the complete healing of his wound. removed or replaced. There was no bacterial growth in either Patient 4. A 35-year-old woman underwent allogeneic the initial culture of blood drawn by venipuncture or subsequent bone marrow transplantation for acute nonlymphocytic leukeblood cultures performed after antimicrobial therapy had been mia. She subsequently developed fever (temperature to 38.8ЊC) started. while neutropenic. Pure growth of L. adecarboxylata was isolated in one of two sets of blood cultures. The isolate was susceptible to all the antimicrobials tested, including amikacin, Results gentamicin, cefazolin, aztreonam, ciprofloxacin, trimethoprimsulfamethoxazole, imipenem, ampicillin, mezlocillin, and Three of the seven patients had lower extremity wound infecchloramphenicol. The patient was treated with vancomycin and tions associated with trauma. One of the remaining four patients ceftazidime and the bacteremia cleared, but she died of her had nosocomial pneumonia, the second had fever while neutrounderlying disease. penic, the third had hemoperitoneum and liver cirrhosis, and Patient 5. A 54-year-old male with a history of reflux the fourth had a central line -associated infection. With the esophagitis, degenerative arthritis, and adult Still's disease deexception of the three patients with positive blood cultures, veloped a fever (temperature, 38.6ЊC) and right lower lobe L. adecarboxylata was isolated as part of a mixed flora. All pneumonia while in the hospital following repair of an inguinal patients except one had fever and leukocytosis. it was the only microorganism isolated from cultures of blood Previous reports, with the exception of the two clinical reports that was obtained while the patients had suspected sepsis. In reviewed above, have dealt mainly with the isolation, identifithese cases, the organism appeared to produce clinical disease; cation, and classification of the organism.
however, additional studies in animals and humans are required There may be several explanations for the lack of reports of to determine the true pathogenic potential of this organism. L. adecarboxylata -associated infections in humans. First, until recently, clinical microbiology laboratories may have been lim-
